{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:13:54Z","timestamp":1789424034518,"version":"build-2803163510"},"reference-count":276,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09022-9","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T09:38:43Z","timestamp":1739266723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders"],"prefix":"10.1007","volume":"68","author":[{"given":"Azhagu Madhavan","family":"Sivalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"9022_CR1","doi-asserted-by":"crossref","unstructured":"Zheng Y, Yan F, He S, Luo L (2024) Targeting ferroptosis in autoimmune diseases: mechanisms and therapeutic prospects. J Autoimmun Res 2024","DOI":"10.1016\/j.autrev.2024.103640"},{"key":"9022_CR2","doi-asserted-by":"publisher","unstructured":"Ren W, Sun Y, Zhao L, Shi X (2024) NLRP3 inflammasome and its role in autoimmune diseases: a promising therapeutic target. Biomed Pharmacother 175. https:\/\/doi.org\/10.1016\/j.biopha.2024.116679","DOI":"10.1016\/j.biopha.2024.116679"},{"issue":"11","key":"9022_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41569-024-01045-7","volume":"21","author":"F Porsch","year":"2024","unstructured":"Porsch F, Binder CJ (2024) Autoimmune diseases and atherosclerotic cardiovascular disease. Nat Rev Cardiol 21(11):780\u2013807. https:\/\/doi.org\/10.1038\/s41569-024-01045-7","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"9022_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28399","volume":"10","author":"Q Li","year":"2024","unstructured":"Li Q, Liu H, Yin G, Xie QJH (2024) Efferocytosis: current status and future prospects in the treatment of autoimmune diseases. Heliyon 10(7):e28399. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28399","journal-title":"Heliyon"},{"key":"9022_CR5","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.3390\/ijms25147666","volume":"25","author":"F Yasmeen","year":"2024","unstructured":"Yasmeen F, Pirzada RH, Ahmad B, Choi B, Choi SJIJOMS (2024) Understanding autoimmunity:mechanisms, predisposing factors, and cytokine therapies. Int J Mol Sci 25:7666","journal-title":"Int J Mol Sci"},{"key":"9022_CR6","doi-asserted-by":"publisher","unstructured":"Thatte AS, Billingsley MM, Weissman D, Melamed JR, Mitchell MJ (2024) Emerging strategies for nanomedicine in autoimmunity. Adv Drug Deliv Rev 115194. https:\/\/doi.org\/10.1016\/j.addr.2024.115194","DOI":"10.1016\/j.addr.2024.115194"},{"key":"9022_CR7","doi-asserted-by":"publisher","first-page":"1322035","DOI":"10.3389\/fimmu.2023.1322035","volume":"14","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wang T, Wu HJFII (2024) Tertiary lymphoid structures in autoimmune diseases. Front Immunol 14:1322035","journal-title":"Front Immunol"},{"key":"9022_CR8","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.csbj.2024.03.026","volume":"23","author":"X Cheng","year":"2024","unstructured":"Cheng X, Meng X, Chen R et al (2024) The molecular subtypes of autoimmune diseases. Comput Struct Biotechnol J 23:1348\u20131363. https:\/\/doi.org\/10.1016\/j.csbj.2024.03.026","journal-title":"Comput Struct Biotechnol J"},{"key":"9022_CR9","doi-asserted-by":"publisher","first-page":"1421528","DOI":"10.3389\/fimmu.2024.1421528","volume":"15","author":"SJFII Tukaj","year":"2024","unstructured":"Tukaj SJFII (2024) Dual role of autoantibodies to heat shock proteins in autoimmune diseases. Front Immunol 15:1421528","journal-title":"Front Immunol"},{"key":"9022_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/ard-2024-225727","volume":"83","author":"G Schett","year":"2024","unstructured":"Schett G, Nagy G, Kr\u00f6nke G, Mielenz D (2024) B-cell depletion in autoimmune diseases. Ann Rheum Dis 83:1409\u20131420. https:\/\/doi.org\/10.1136\/ard-2024-225727","journal-title":"Ann Rheum Dis"},{"key":"9022_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/v16010133","volume":"16","author":"MA De Francesco","year":"2024","unstructured":"De Francesco MA (2024) Herpesviridae, neurodegenerative disorders and autoimmune diseases: What is the relationship between them? Viruses 16:133. https:\/\/doi.org\/10.3390\/v16010133","journal-title":"Viruses"},{"key":"9022_CR12","doi-asserted-by":"publisher","unstructured":"Goyal R, Wilson K, Saharan A et al (2024) Insights on aspects of apoptosis in neurodegenerative disorders: a comprehensive review. Explor Med:89\u2013100. https:\/\/doi.org\/10.37349\/emed.2024.00208","DOI":"10.37349\/emed.2024.00208"},{"key":"9022_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13808","volume":"30","author":"Y Ma","year":"2024","unstructured":"Ma Y, Lai J, Wan Q et al (2024) Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis. Skin Res Technol 30:e13808. https:\/\/doi.org\/10.1111\/srt.13808","journal-title":"Skin Res Technol"},{"key":"9022_CR14","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.immuni.2024.08.005","volume":"57","author":"C Saggau","year":"2024","unstructured":"Saggau C, Bacher P, Esser D et al (2024) Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases. Immunity 57:2416\u20132432.e8. https:\/\/doi.org\/10.1016\/j.immuni.2024.08.005","journal-title":"Immunity"},{"key":"9022_CR15","doi-asserted-by":"publisher","first-page":"1374938","DOI":"10.3389\/fimmu.2024.1374938","volume":"15","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhou X, Liu K et al (2024) Exploring risk factors for autoimmune diseases complicated by nonhodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study. Front Immunol 15:1374938. https:\/\/doi.org\/10.3389\/fimmu.2024.1374938","journal-title":"Front Immunol"},{"key":"9022_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s11033-024-09735-8","volume":"51","author":"SIS Al-Hawary","year":"2024","unstructured":"Al-Hawary SIS, Jasim SA, Hjazi A et al (2024) Correction: A new perspective on therapies involving Bcell depletion in autoimmune diseases. Mol Biol Rep 51:880. https:\/\/doi.org\/10.1007\/s11033-024-09735-8","journal-title":"Mol Biol Rep"},{"key":"9022_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40588-023-00213-6","volume":"11","author":"F Sadeghpour Heravi","year":"2024","unstructured":"Sadeghpour Heravi F (2024) Gut Microbiota and autoimmune diseases: Mechanisms, treatment, challenges, and future recommendations. Curr Clin Microbiol Rep 11:18\u201333. https:\/\/doi.org\/10.1007\/s40588-023-00213-6","journal-title":"Curr Clin Microbiol Rep"},{"key":"9022_CR18","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","volume":"57","author":"JG Cyster","year":"2024","unstructured":"Cyster JG, Wilson PC (2024) Antibody modulation of B cell responses\u2014Incorporating positive and negative feedback. Immunity 57:1466\u20131481. https:\/\/doi.org\/10.1016\/j.immuni.2024.06.009","journal-title":"Immunity"},{"key":"9022_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111170","volume":"85","author":"AA Altoum","year":"2024","unstructured":"Altoum AA, Oghenemaro EF, Pallathadka H et al (2024) lncRNA-mediated immune system dysregulation in RIF; a comprehensive insight into immunological modifications and signaling pathways\u2019 dysregulation. Hum Immunol 85:111170. https:\/\/doi.org\/10.1016\/j.humimm.2024.111170","journal-title":"Hum Immunol"},{"key":"9022_CR20","doi-asserted-by":"publisher","first-page":"1339714","DOI":"10.3389\/fimmu.2024.1339714","volume":"15","author":"F Shirafkan","year":"2024","unstructured":"Shirafkan F, Hensel L, Rattay K (2024) Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis. Front Immunol 15:1339714. https:\/\/doi.org\/10.3389\/fimmu.2024.1339714","journal-title":"Front Immunol"},{"key":"9022_CR21","doi-asserted-by":"publisher","unstructured":"Singh PK, Stan RC (2024) ThermoPCD: a database of molecular dynamics trajectories of antibody\u2013antigen complexes at physiologic and fever-range temperatures. Database (Oxford) 2024. https:\/\/doi.org\/10.1093\/database\/baae015","DOI":"10.1093\/database\/baae015"},{"key":"9022_CR22","doi-asserted-by":"publisher","unstructured":"Wang X, Yuan W, Yang C et al (2024) Emerging role of gut microbiota in autoimmune diseases. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1365554","DOI":"10.3389\/fimmu.2024.1365554"},{"key":"9022_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/imm.13869","volume":"174","author":"Y Yang","year":"2025","unstructured":"Yang Y, Shao Y, Gao X et al (2025) RGS10 deficiency alleviated intestinal mucosal inflammation through suppression of Th1\/Th17 cell immune responses in ulcerative colitis. Immunology 174:139\u2013152. https:\/\/doi.org\/10.1111\/imm.13869","journal-title":"Immunology"},{"key":"9022_CR24","doi-asserted-by":"publisher","unstructured":"Borghol AH, Bitar ER, Hanna A et al (2024) The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases. Crit Rev Microbiol 1\u201321. https:\/\/doi.org\/10.1080\/1040841X.2024.2344114","DOI":"10.1080\/1040841X.2024.2344114"},{"key":"9022_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2023.111203","volume":"55","author":"L Cai","year":"2024","unstructured":"Cai L, Lv Y, Yan Q, Guo W (2024) Cytokines: The links between bone and the immune system. Injury 55:111203. https:\/\/doi.org\/10.1016\/j.injury.2023.111203","journal-title":"Injury"},{"key":"9022_CR26","doi-asserted-by":"publisher","first-page":"2319207","DOI":"10.1080\/08916934.2024.2319207","volume":"57","author":"W Zheng","year":"2024","unstructured":"Zheng W, Tang Y, Cheng M et al (2024) Dysregulated CXCL12 expression in osteoblasts promotes Blymphocytes preferentially homing to the bone marrow in MRL\/lpr mice. Autoimmunity 57:2319207. https:\/\/doi.org\/10.1080\/08916934.2024.2319207","journal-title":"Autoimmunity"},{"key":"9022_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41577-023-00897-3","volume":"24","author":"T Inoue","year":"2024","unstructured":"Inoue T, Kurosaki T (2024) Memory B cells. Nat Rev Immunol 24:5\u201317. https:\/\/doi.org\/10.1038\/s41577-023-00897-3","journal-title":"Nat Rev Immunol"},{"key":"9022_CR28","doi-asserted-by":"publisher","unstructured":"Scaletti C, Pratesi S, Bellando Randone S et al (2025) The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapies. Clin Exp Immunol 219(1):uxae098. https:\/\/doi.org\/10.1093\/cei\/uxae098","DOI":"10.1093\/cei\/uxae098"},{"key":"9022_CR29","doi-asserted-by":"publisher","unstructured":"Wang R, Lan C, Benlagha K et al (2024) The interaction of innate immune and adaptive immune system. MedComm 5(10):e714. https:\/\/doi.org\/10.1002\/mco2.714","DOI":"10.1002\/mco2.714"},{"key":"9022_CR30","doi-asserted-by":"publisher","unstructured":"Kashimura M (2024) Blood defense system \u2013 Proposal for a new concept of an immune system against blood borne pathogens comprising the liver, spleen and bone marrow. Scand J Immunol 99(5):e13363. https:\/\/doi.org\/10.1111\/sji.13363","DOI":"10.1111\/sji.13363"},{"key":"9022_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41581-023-00791-0","volume":"20","author":"PS Heeger","year":"2024","unstructured":"Heeger PS, Haro MC, Jordan S (2024) Translating B cell immunology to the treatment of antibodymediated allograft rejection. Nat Rev Nephrol 20:218\u2013232. https:\/\/doi.org\/10.1038\/s41581-023-00791-0","journal-title":"Nat Rev Nephrol"},{"key":"9022_CR32","doi-asserted-by":"publisher","unstructured":"Lemos JRN, Hirani K, von Herrath M (2024) Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol 14:1326711. https:\/\/doi.org\/10.3389\/fimmu.2023.1326711","DOI":"10.3389\/fimmu.2023.1326711"},{"key":"9022_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12016-024-09003-4","volume":"66","author":"T Deng","year":"2024","unstructured":"Deng T, Wang Z, Geng Q et al (2024) Methylation of T and B lymphocytes in autoimmune rheumatic diseases. Clin Rev Allergy Immunol 66:401\u2013422. https:\/\/doi.org\/10.1007\/s12016-024-09003-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"9022_CR34","first-page":"62","volume":"2","author":"E Obeagu","year":"2024","unstructured":"Obeagu E, Obeagu GJEJOI (2024) Immunodeficiency and immune reconstitution in pediatric HIV:mechanisms, challenges, and therapeutic strategies. Elite J Immunol 2:62\u201379","journal-title":"Elite J Immunol"},{"key":"9022_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","volume":"548","author":"Z Khan","year":"2024","unstructured":"Khan Z, Mehan S, Gupta GD, Narula AS (2024) Immune system dysregulation in the progression of multiple sclerosis: Molecular insights and therapeutic implications. Neuroscience 548:9\u201326. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.04.004","journal-title":"Neuroscience"},{"key":"9022_CR36","doi-asserted-by":"publisher","unstructured":"Yu L, Fu Y, Miao R et al (2024) Regulatory T cells and their derived cell pharmaceuticals as emerging therapeutics against autoimmune diseases. Adv Funct Mater. https:\/\/doi.org\/10.1002\/adfm.202405133","DOI":"10.1002\/adfm.202405133"},{"key":"9022_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tem.2024.01.005","volume":"35","author":"S Wang","year":"2024","unstructured":"Wang S, Yang N, Zhang H (2024) Metabolic dysregulation of lymphocytes in autoimmune diseases. Trends Endocrinol Metab 35:624\u2013637. https:\/\/doi.org\/10.1016\/j.tem.2024.01.005","journal-title":"Trends Endocrinol Metab"},{"key":"9022_CR38","doi-asserted-by":"publisher","unstructured":"Anvar MT, Rashidan K, Arsam N, et al (2024) Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? Cancer Cell Int 24:355. https:\/\/doi.org\/10.1186\/s12935-024-03525-9","DOI":"10.1186\/s12935-024-03525-"},{"key":"9022_CR39","doi-asserted-by":"publisher","unstructured":"Chandwaskar R, Dalal R, Gupta S et al (2024) Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease. Scand J Immunol 100)6):e13412. https:\/\/doi.org\/10.1111\/sji.13412","DOI":"10.1111\/sji.13412"},{"key":"9022_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/antib13010010","volume":"13","author":"V Chasov","year":"2024","unstructured":"Chasov V, Zmievskaya E, Ganeeva I et al (2024) Immunotherapy strategy for systemic autoimmune diseases: Betting on CAR-T cells and antibodies. Antibodies (Basel) 13:10. https:\/\/doi.org\/10.3390\/antib13010010","journal-title":"Antibodies (Basel)"},{"key":"9022_CR41","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi H, Pepper M, Thomas PG (2024) Principles and therapeutic applications of adaptive immunity. Cell 187:2052\u20132078. https:\/\/doi.org\/10.1016\/j.cell.2024.03.037","journal-title":"Cell"},{"key":"9022_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom14020187","volume":"14","author":"Z Xiang","year":"2024","unstructured":"Xiang Z, Yin X, Wei L et al (2024) LILRB4 checkpoint for immunotherapy: Structure, mechanism and disease targets. Biomolecules 14:187. https:\/\/doi.org\/10.3390\/biom14020187","journal-title":"Biomolecules"},{"key":"9022_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100473","volume":"4","author":"Y Yasumizu","year":"2024","unstructured":"Yasumizu Y, Takeuchi D, Morimoto R et al (2024) Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases. Cell Genom 4:100473. https:\/\/doi.org\/10.1016\/j.xgen.2023.100473","journal-title":"Cell Genom"},{"key":"9022_CR44","doi-asserted-by":"publisher","unstructured":"Wang K, Huang H, Zhan Q et al (2024) Toll-like receptors in health and disease. MedComm 5. https:\/\/doi.org\/10.1002\/mco2.549","DOI":"10.1002\/mco2.549"},{"key":"9022_CR45","doi-asserted-by":"publisher","unstructured":"Soussan S, Pupier G, Cremer I et al (2024) Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anticheckpoint monoclonal antibody therapies. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1343020","DOI":"10.3389\/fimmu.2024.1343020"},{"key":"9022_CR46","doi-asserted-by":"publisher","unstructured":"Yang B, Ma D, Zhu X et al (2024) Roles of TRP and PIEZO receptors in autoimmune diseases. Expert Rev Mol Med 26. https:\/\/doi.org\/10.1017\/erm.2023.23","DOI":"10.1017\/erm.2023.23"},{"key":"9022_CR47","doi-asserted-by":"publisher","unstructured":"Xu L, Jiao J, Liu M et al (2023) A combination of CPI-0610 and SAHA induces apoptosis through STAT3 and p38 signalling pathways in diffuse large B-cell lymphoma cells. Curr Med Chem 31. https:\/\/doi.org\/10.2174\/0109298673244868231017043517","DOI":"10.2174\/0109298673244868231017043517"},{"key":"9022_CR48","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.tibtech.2024.01.006","volume":"42","author":"M Zouali","year":"2024","unstructured":"Zouali M (2024) Engineered immune cells as therapeutics for autoimmune diseases. Trends Biotechnol 42:842\u2013858. https:\/\/doi.org\/10.1016\/j.tibtech.2024.01.006","journal-title":"Trends Biotechnol"},{"key":"9022_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/hum.2024.114","volume":"35","author":"AE Araujo","year":"2024","unstructured":"Araujo AE, Bentler M, Perez Garmendia X et al (2024) Adeno-associated virus vectors-a target of cellular and humoral immunity-are expanding their reach toward hematopoietic stem cell modification and immunotherapies. Hum Gene Ther 35:586\u2013603. https:\/\/doi.org\/10.1089\/hum.2024.114","journal-title":"Hum Gene Ther"},{"key":"9022_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037718","volume":"103","author":"S Tian","year":"2024","unstructured":"Tian S, Wang Y, Wan J et al (2024) Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: a review. Medicine (Baltimore) 103:e37718. https:\/\/doi.org\/10.1097\/MD.0000000000037718","journal-title":"Medicine (Baltimore)"},{"key":"9022_CR51","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.37275\/bsm.v8i5.988","volume":"8","author":"H Gustin","year":"2024","unstructured":"Gustin H, Raveinal, Elvira D (2024) T cell dysfunction in systemic lupus erythematosus. Bioscmed 8:4374\u20134387. https:\/\/doi.org\/10.37275\/bsm.v8i5.988","journal-title":"Bioscmed"},{"key":"9022_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115994","volume":"220","author":"Q Jia","year":"2024","unstructured":"Jia Q, Che Q, Zhang X et al (2024) Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-\u03b1-induced activation of fibroblast-like synoviocytes. Biochem Pharmacol 220:115994. https:\/\/doi.org\/10.1016\/j.bcp.2023.115994","journal-title":"Biochem Pharmacol"},{"key":"9022_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117177","volume":"178","author":"NK Bhol","year":"2024","unstructured":"Bhol NK, Bhanjadeo MM, Singh AK et al (2024) The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed Pharmacother 178:117177. https:\/\/doi.org\/10.1016\/j.biopha.2024.117177","journal-title":"Biomed Pharmacother"},{"key":"9022_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/tropicalmed9010013","volume":"9","author":"AA Al-Qahtani","year":"2024","unstructured":"Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA (2024) Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: A comprehensive review. Trop Med Infect Dis 9:13. https:\/\/doi.org\/10.3390\/tropicalmed9010013","journal-title":"Trop Med Infect Dis"},{"key":"9022_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-99-9029-0_1","volume-title":"Studies in Computational Intelligence","author":"S Kumar","year":"2024","unstructured":"Kumar S, Kaushik D, Sharma SK (2024) Autoimmune disorders: Types, symptoms, and risk factors. In: Studies in Computational Intelligence. Springer Nature Singapore, Singapore, pp 3\u201331. https:\/\/doi.org\/10.1007\/978-981-99-9029-0_1"},{"key":"9022_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","volume":"21","author":"P-F Wang","year":"2024","unstructured":"Wang P-F, Jiang F, Zeng Q-M et al (2024) Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. J Neuroinflammation 21:28. https:\/\/doi.org\/10.1186\/s12974-024-03016-8","journal-title":"J Neuroinflammation"},{"key":"9022_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112724","volume":"140","author":"Q Huang","year":"2024","unstructured":"Huang Q, Zhu J (2024) Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence. Int Immunopharmacol 140:112724. https:\/\/doi.org\/10.1016\/j.intimp.2024.112724","journal-title":"Int Immunopharmacol"},{"key":"9022_CR58","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4049\/jimmunol.2300216","volume":"213","author":"S Grebinoski","year":"2024","unstructured":"Grebinoski S, Pieklo G, Zhang Q et al (2024) Regulatory T cell insufficiency in autoimmune diabetes is driven by selective loss of neuropilin-1 on intraislet regulatory T cells. J Immunol 213:779\u2013794. https:\/\/doi.org\/10.4049\/jimmunol.2300216","journal-title":"J Immunol"},{"key":"9022_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2024.101043","volume":"94","author":"S Fiordoro","year":"2024","unstructured":"Fiordoro S, Rosano C, Pechkova E et al (2024) Epigenetic modulation of immune cells: mechanisms and implications. Adv Biol Regul 94:101043. https:\/\/doi.org\/10.1016\/j.jbior.2024.101043","journal-title":"Adv Biol Regul"},{"key":"9022_CR60","doi-asserted-by":"publisher","unstructured":"Anilkumar AS, Veerabathiran R (2024) The impact of Epstein-Barr virus on autoimmune neuromuscular disorders: A comparative study of myasthenia gravis and guillain\u2013barre syndrome. Curr Treat Options Neurol. https:\/\/doi.org\/10.1007\/s11940-024-00809-3","DOI":"10.1007\/s11940-024-00809-3"},{"key":"9022_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/microorganisms12020362","volume":"12","author":"L Sokolovska","year":"2024","unstructured":"Sokolovska L, Cistjakovs M, Matroze A et al (2024) From viral infection to autoimmune reaction: Exploring the link between human Herpesvirus 6 and autoimmune diseases. Microorganisms 12:362. https:\/\/doi.org\/10.3390\/microorganisms12020362","journal-title":"Microorganisms"},{"key":"9022_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"J-L Teillaud","year":"2024","unstructured":"Teillaud J-L, Houel A, Panouillot M et al (2024) Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer 24:629\u2013646. https:\/\/doi.org\/10.1038\/s41568-024-00728-0","journal-title":"Nat Rev Cancer"},{"key":"9022_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu M, Ren Y et al (2024) Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Mol Cancer 23:75. https:\/\/doi.org\/10.1186\/s12943-024-01980-6","journal-title":"Mol Cancer"},{"key":"9022_CR64","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2174\/0115734013252358231016181809","volume":"20","author":"PE Dos Santos","year":"2024","unstructured":"Dos Santos PE, de Oliveira RC, Massaut KB et al (2024) Probiotics: Therapeutic strategy on the prevention and treatment of inflammatory diseases: Obesity, type 2 diabetes mellitus and celiac disease. Curr Nutr Food Sci 20:1112\u20131125. https:\/\/doi.org\/10.2174\/0115734013252358231016181809","journal-title":"Curr Nutr Food Sci"},{"key":"9022_CR65","doi-asserted-by":"publisher","unstructured":"Solovev I, Sergeeva A, Geraskina A et al (2024) Aging and physiological barriers: mechanisms of barrier integrity changes and implications for age-related diseases. Mol Biol Rep 51. https:\/\/doi.org\/10.1007\/s11033-024-09833-7","DOI":"10.1007\/s11033-024-09833-7"},{"key":"9022_CR66","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s43587-024-00597-0","volume":"4","author":"R Wu","year":"2024","unstructured":"Wu R, Sun F, Zhang W et al (2024) Targeting aging and age-related diseases with vaccines. Nat Aging 4:464\u2013482. https:\/\/doi.org\/10.1038\/s43587-024-00597-0","journal-title":"Nat Aging"},{"key":"9022_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103073","volume":"21","author":"N Lavine","year":"2022","unstructured":"Lavine N, Ohayon A, Mahroum N (2022) Renal autoimmunity: The role of bacterial and viral infections, an extensive review. Autoimmun Rev 21:103073. https:\/\/doi.org\/10.1016\/j.autrev.2022.103073","journal-title":"Autoimmun Rev"},{"key":"9022_CR68","doi-asserted-by":"publisher","first-page":"0001.1","DOI":"10.34133\/jbioxresearch.00","volume":"7","author":"MF Olaniyan","year":"2024","unstructured":"Olaniyan MF, Oladele AA, Tijani A, Muhibi MA, Olaniyan TB (2024) Susceptible genes and polymorphisms associated with communicable and noncommunicable diseases. J Bio-X Res 7:0001.1. https:\/\/doi.org\/10.34133\/jbioxresearch.00","journal-title":"J Bio-X Res"},{"key":"9022_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12967-024-05247-y","volume":"22","author":"W Gao","year":"2024","unstructured":"Gao W, Peng C, Wang Z et al (2024) Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study. J Transl Med 22:425. https:\/\/doi.org\/10.1186\/s12967-024-05247-y","journal-title":"J Transl Med"},{"key":"9022_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000540959","volume":"31","author":"RH Straub","year":"2024","unstructured":"Straub RH, Cutolo M (2024) A history of psycho-neuro-endocrine immune interactions in rheumatic diseases. Neuroimmunomodulation 31:183\u2013210. https:\/\/doi.org\/10.1159\/000540959","journal-title":"Neuroimmunomodulation"},{"key":"9022_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/ars.2022.0117","volume":"40","author":"LC D\u2019Souza","year":"2024","unstructured":"D\u2019Souza LC, Paithankar JG, Stopper H et al (2024) Environmental chemical-induced reactive oxygen species generation and immunotoxicity: A comprehensive review. Antioxid Redox Signal 40:691\u2013714. https:\/\/doi.org\/10.1089\/ars.2022.0117","journal-title":"Antioxid Redox Signal"},{"key":"9022_CR72","doi-asserted-by":"publisher","first-page":"1361884","DOI":"10.3389\/fimmu.2023.1361884","volume":"14","author":"SE Dunn","year":"2023","unstructured":"Dunn SE, Correale J, Gommerman JL, Horwitz MS (2023) Editorial: Environmental factors in autoimmunity. Front Immunol 14:1361884. https:\/\/doi.org\/10.3389\/fimmu.2023.1361884","journal-title":"Front Immunol"},{"key":"9022_CR73","doi-asserted-by":"publisher","unstructured":"Ghorbanzadeh S, Khojini JY, Abouali R et al (2024) Clearing the path: Exploring apoptotic cell clearance in inflammatory and autoimmune disorders for therapeutic advancements. Mol Biotechnol. https:\/\/doi.org\/10.1007\/s12033-024-01222-6","DOI":"10.1007\/s12033-024-01222-6"},{"key":"9022_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/intimm\/dxae032","volume":"36","author":"T Ebihara","year":"2024","unstructured":"Ebihara T, Yamada T, Fuchimukai A et al (2024) Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death. Int Immunol 36:585\u2013594. https:\/\/doi.org\/10.1093\/intimm\/dxae032","journal-title":"Int Immunol"},{"key":"9022_CR75","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41467-024-46606-z","volume":"15","author":"RRCE Schreurs","year":"2024","unstructured":"Schreurs RRCE, Koulis A, Booiman T et al (2024) Autophagy-enhancing ATG16L1 polymorphism is associated with improved clinical outcome and T-cell immunity in chronic HIV-1 infection. Nat Commun 15:2465. https:\/\/doi.org\/10.1038\/s41467-024-46606-z","journal-title":"Nat Commun"},{"key":"9022_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imr.13362","volume":"325","author":"C Yau","year":"2024","unstructured":"Yau C, Danska JS (2024) Cracking the type 1 diabetes code: Genes, microbes, immunity, and the early life environment. Immunol Rev 325:23\u201345. https:\/\/doi.org\/10.1111\/imr.13362","journal-title":"Immunol Rev"},{"key":"9022_CR77","doi-asserted-by":"publisher","unstructured":"Snijckers RPM, Foks AC (2024) Adaptive immunity and atherosclerosis: aging at its crossroads. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1350471","DOI":"10.3389\/fimmu.2024.1350471"},{"key":"9022_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.13356","volume":"325","author":"A Schnell","year":"2024","unstructured":"Schnell A (2024) Stem-like T cells in cancer and autoimmunity. Immunol Rev 325:9\u201322. https:\/\/doi.org\/10.1111\/imr.13356","journal-title":"Immunol Rev"},{"key":"9022_CR79","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.bpj.2024.05.020","volume":"123","author":"J Rogers","year":"2024","unstructured":"Rogers J, Bajur AT, Salaita K, Spillane KM (2024) Mechanical control of antigen detection and discrimination by T and B cell receptors. Biophys J 123:2234\u20132255. https:\/\/doi.org\/10.1016\/j.bpj.2024.05.020","journal-title":"Biophys J"},{"key":"9022_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103218","volume":"145","author":"X Zou","year":"2024","unstructured":"Zou X, Huo F, Sun L, Huang J (2024) Peripheral helper T cells in human diseases. J Autoimmun 145:103218. https:\/\/doi.org\/10.1016\/j.jaut.2024.103218","journal-title":"J Autoimmun"},{"key":"9022_CR81","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/ptr.816","volume":"38","author":"R Damare","year":"2024","unstructured":"Damare R, Engle K, Kumar G (2024) Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. Phytother Res 38:2406\u20132447. https:\/\/doi.org\/10.1002\/ptr.816","journal-title":"Phytother Res"},{"key":"9022_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110182","volume":"262","author":"M Mizui","year":"2024","unstructured":"Mizui M, Kono M (2024) Novel therapeutic strategies targeting abnormal T-cell signaling in systemic lupus erythematosus. Clin Immunol 262:110182. https:\/\/doi.org\/10.1016\/j.clim.2024.110182","journal-title":"Clin Immunol"},{"key":"9022_CR83","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e10","volume":"24","author":"YE Lee","year":"2024","unstructured":"Lee YE, Lee S-H, Kim W-U (2024) Cytokines, vascular endothelial growth factors, and PlGF in autoimmunity: Insights from rheumatoid arthritis to multiple sclerosis. Immune Netw 24:e10. https:\/\/doi.org\/10.4110\/in.2024.24.e10","journal-title":"Immune Netw"},{"key":"9022_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100277","volume":"10","author":"MK Karuppan Perumal","year":"2024","unstructured":"Karuppan Perumal MK, Renuka RR, Thangavelu L, Srinivasan GP (2024) The impact of innate immunity and inflammation on the development of oral cancer and their role in tumor promotion and suppression. Oral Oncology Reports 10:100277. https:\/\/doi.org\/10.1016\/j.oor.2024.100277","journal-title":"Oral Oncology Reports"},{"key":"9022_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106461","volume":"193","author":"J Zeng","year":"2024","unstructured":"Zeng J, Liao Z, Yang H et al (2024) T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer\u2019s disease. Neurobiol Dis 193:106461. https:\/\/doi.org\/10.1016\/j.nbd.2024.106461","journal-title":"Neurobiol Dis"},{"key":"9022_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2024.102866","volume":"4","author":"M Thiruvengadam","year":"2024","unstructured":"Thiruvengadam M (2024) Neuroinflammation: Unraveling its role in neurodegenerative diseases. Brain Spine 4:102866. https:\/\/doi.org\/10.1016\/j.bas.2024.102866","journal-title":"Brain Spine"},{"key":"9022_CR87","doi-asserted-by":"publisher","unstructured":"Choi J, Crotty S, Choi YS (2024) Cytokines in follicular helper T cell biology in physiologic and pathologic conditions. Immune Netw 24. https:\/\/doi.org\/10.4110\/in.2024.24.e8","DOI":"10.4110\/in.2024.24.e8"},{"key":"9022_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103544","volume":"23","author":"Y Wu","year":"2024","unstructured":"Wu Y, Wang Q, Jia S et al (2024) Gut-tropic T cells and extra-intestinal autoimmune diseases. Autoimmun Rev 23:103544. https:\/\/doi.org\/10.1016\/j.autrev.2024.103544","journal-title":"Autoimmun Rev"},{"key":"9022_CR89","doi-asserted-by":"publisher","first-page":"1446072","DOI":"10.3389\/fimmu.2024.1446072","volume":"15","author":"LE Carreto-Binaghi","year":"2024","unstructured":"Carreto-Binaghi LE, Sztein MB, Booth JS (2024) Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens. Front Immunol 15:1446072. https:\/\/doi.org\/10.3389\/fimmu.2024.1446072","journal-title":"Front Immunol"},{"key":"9022_CR90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/microorganisms12010230","volume":"12","author":"A Vojdani","year":"2024","unstructured":"Vojdani A, Koksoy S, Vojdani E et al (2024) Natural killer cells and cytotoxic T cells: Complementary partners against microorganisms and cancer. Microorganisms 12:230. https:\/\/doi.org\/10.3390\/microorganisms12010230","journal-title":"Microorganisms"},{"key":"9022_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105972","volume":"229","author":"Z Xie","year":"2024","unstructured":"Xie Z, Protzer U (2024) Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B. Antiviral Res 229:105972. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105972","journal-title":"Antiviral Res"},{"key":"9022_CR92","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/B978-0-443-23947-2.00075-8","volume-title":"Autoimmune (type 1) diabetes. In: The Rose and Mackay textbook of autoimmune diseases","author":"F D\u2019Addio","year":"2024","unstructured":"D\u2019Addio F, Nasr MB, Lunati ME, Fiorina P (2024) Autoimmune (type 1) diabetes. In: The Rose and Mackay textbook of autoimmune diseases, 7th edn. Elsevier, pp 585\u2013601. https:\/\/doi.org\/10.1016\/B978-0-443-23947-2.00075-8","edition":"7"},{"key":"9022_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292028","volume":"19","author":"A Carvalho-Santos","year":"2024","unstructured":"Carvalho-Santos A, Ballard Kuhnert LR, Hahne M et al (2024) Anti-inflammatory role of APRIL by modulating regulatory B cells in antigen-induced arthritis. PLoS One 19:e0292028. https:\/\/doi.org\/10.1371\/journal.pone.0292028","journal-title":"PLoS One"},{"key":"9022_CR94","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/art.42922","volume":"76","author":"C Triaille","year":"2024","unstructured":"Triaille C, Tilman G, Baert CA et al (2024) Two broad categories overlapping with rheumatoid arthritis observed in synovial biopsies from patients with juvenile idiopathic arthritis. Arthritis Rheumatol 76:1439\u20131445. https:\/\/doi.org\/10.1002\/art.42922","journal-title":"Arthritis Rheumatol"},{"key":"9022_CR95","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1186\/s12967-024-05450-x","volume":"22","author":"H Hu","year":"2024","unstructured":"Hu H, Li H, Li R et al (2024) Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17\/Treg balance. J Transl Med 22:663. https:\/\/doi.org\/10.1186\/s12967-024-05450-x","journal-title":"J Transl Med"},{"key":"9022_CR96","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida TS, Cheru NT, Hafler DA (2024) The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat Rev Immunol 24:503\u2013517. https:\/\/doi.org\/10.1038\/s41577-024-00994-x","journal-title":"Nat Rev Immunol"},{"key":"9022_CR97","doi-asserted-by":"publisher","unstructured":"Lucas ED, Huggins MA, Peng C et al (2024) Circulating KLRG1 + long-lived effector memory T cells retain the flexibility to become tissue resident. Sci Immunol 9. https:\/\/doi.org\/10.1126\/sciimmunol.adj8356","DOI":"10.1126\/sciimmunol.adj8356"},{"key":"9022_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12016-024-08982-8","volume":"66","author":"B Long","year":"2024","unstructured":"Long B, Zhou S, Gao Y et al (2024) Tissue-resident memory T cells in allergy. Clin Rev Allergy Immunol 66:64\u201375. https:\/\/doi.org\/10.1007\/s12016-024-08982-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"9022_CR99","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4049\/jimmunol.2200756","volume":"212","author":"SK Brookens","year":"2024","unstructured":"Brookens SK, Cho SH, Paik Y et al (2024) Plasma cell differentiation, antibody quality, and initial germinal center B cell population depend on glucose influx rate. J Immunol 212:43\u201356. https:\/\/doi.org\/10.4049\/jimmunol.2200756","journal-title":"J Immunol"},{"key":"9022_CR100","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s44318-024-00077-6","volume":"43","author":"K Ochiai","year":"2024","unstructured":"Ochiai K, Shima H, Tamahara T et al (2024) Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions. EMBO J 43:1947\u20131964. https:\/\/doi.org\/10.1038\/s44318-024-00077-6","journal-title":"EMBO J"},{"key":"9022_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2024.07.008","volume":"79","author":"Z Chen","year":"2024","unstructured":"Chen Z, Jiang P, Su D et al (2024) Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease. Cytokine Growth Factor Rev 79:1\u201315. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.07.008","journal-title":"Cytokine Growth Factor Rev"},{"key":"9022_CR102","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/cancers16061226","volume":"16","author":"M Absmaier-Kijak","year":"2024","unstructured":"Absmaier-Kijak M, Iuliano C, Kaesler S et al (2024) T-cell subtypes and immune signatures in cutaneous immune-related adverse events in melanoma patients under immune checkpoint inhibitor therapy. Cancers (Basel) 16:1226. https:\/\/doi.org\/10.3390\/cancers16061226","journal-title":"Cancers (Basel)"},{"key":"9022_CR103","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/08830185.2024.2395274","volume":"43","author":"M Tolomeo","year":"2024","unstructured":"Tolomeo M, Cascio A (2024) STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases. Int Rev Immunol 43:394\u2013418. https:\/\/doi.org\/10.1080\/08830185.2024.2395274","journal-title":"Int Rev Immunol"},{"key":"9022_CR104","doi-asserted-by":"publisher","unstructured":"Yanagihara S, Yuba E, Harada A (2024) The impact of size for liposomes modified with pH-responsive \u03b2-glucan derivatives on the initiation of cellular and humoral immune responses in murine models. Biotechnol Biotechnol Equip 38. https:\/\/doi.org\/10.1080\/13102818.2024.2358992","DOI":"10.1080\/13102818.2024.2358992"},{"key":"9022_CR105","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41590-024-01909-7","volume":"25","author":"O Fesneau","year":"2024","unstructured":"Fesneau O, Thevin V, Pinet V et al (2024) An intestinal TH17 cell-derived subset can initiate cancer. Nat Immunol 25:1637\u20131649. https:\/\/doi.org\/10.1038\/s41590-024-01909-7","journal-title":"Nat Immunol"},{"key":"9022_CR106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41422-024-00929-0","volume":"34","author":"Y Lin","year":"2024","unstructured":"Lin Y, Wan Z, Liu B et al (2024) B cell-reactive triad of B cells, follicular helper and regulatory T cells at homeostasis. Cell Res 34:295\u2013308. https:\/\/doi.org\/10.1038\/s41422-024-00929-0","journal-title":"Cell Res"},{"key":"9022_CR107","doi-asserted-by":"publisher","unstructured":"Scherlinger M, Li H, Pan W et al (2024) CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nat Commun 15. https:\/\/doi.org\/10.1038\/s41467-024-45080-x","DOI":"10.1038\/s41467-024-45080-x"},{"key":"9022_CR108","doi-asserted-by":"publisher","first-page":"1434011","DOI":"10.3389\/fimmu.2024.1434011","volume":"15","author":"L Bettin","year":"2024","unstructured":"Bettin L, Darbellay J, van Kessel J et al (2024) Porcine \u03b3\u03b4 T cells express cytotoxic cell-associated markers and display killing activity but are not selectively cytotoxic against PRRSV- or swIAV-infected macrophages. Front Immunol 15:1434011. https:\/\/doi.org\/10.3389\/fimmu.2024.1434011","journal-title":"Front Immunol"},{"key":"9022_CR109","doi-asserted-by":"publisher","unstructured":"Hj\u00e1lmsd\u00f3ttir \u00c1, Hasler F, Waeckerle-Men Y et al (2024) T cell independent antibody responses with class switch and memory using peptides anchored on liposomes. NPJ Vaccines 9. https:\/\/doi.org\/10.1038\/s41541-024-00902-3","DOI":"10.1038\/s41541-024-00902-3"},{"key":"9022_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000497","volume":"3","author":"N Nakamura","year":"2024","unstructured":"Nakamura N, Kobashi Y, Kim KS et al (2024) Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population. PLOS Digit Health 3:e0000497. https:\/\/doi.org\/10.1371\/journal.pdig.0000497","journal-title":"PLOS Digit Health"},{"key":"9022_CR111","doi-asserted-by":"publisher","unstructured":"Hale BD, Severin Y, Graebnitz F et al (2024) Cellular architecture shapes the na\u00efve T cell response. Science 384. https:\/\/doi.org\/10.1126\/science.adh8967","DOI":"10.1126\/science.adh8967"},{"key":"9022_CR112","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41590-024-01899-6","volume":"25","author":"Y You","year":"2024","unstructured":"You Y, Dunst J, Ye K et al (2024) Direct presentation of inflammation-associated self-antigens by thymic innate-like T cells induces elimination of autoreactive CD8+ thymocytes. Nat Immunol 25:1367\u20131382. https:\/\/doi.org\/10.1038\/s41590-024-01899-6","journal-title":"Nat Immunol"},{"key":"9022_CR113","doi-asserted-by":"publisher","unstructured":"Degn SE, Tolar P (2024) Towards a unifying model for B-cell receptor triggering. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-024-01073-x","DOI":"10.1038\/s41577-024-01073-x"},{"key":"9022_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011639","volume":"20","author":"LM Sircy","year":"2024","unstructured":"Sircy LM, Ramstead AG, Gibbs LC et al (2024) Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection. PLoS Pathog 20:e1011639. https:\/\/doi.org\/10.1371\/journal.ppat.1011639","journal-title":"PLoS Pathog"},{"key":"9022_CR115","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-023-06937-1","volume":"626","author":"I Uddb\u00e4ck","year":"2024","unstructured":"Uddb\u00e4ck I, Michalets SE, Saha A et al (2024) Prevention of respiratory virus transmission by resident memory CD8+ T cells. Nature 626:392\u2013400. https:\/\/doi.org\/10.1038\/s41586-023-06937-1","journal-title":"Nature"},{"key":"9022_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114332","volume":"43","author":"KJ Susa","year":"2024","unstructured":"Susa KJ, Bradshaw GA, Eisert RJ et al (2024) A spatiotemporal map of co-receptor signaling networks underlying B cell activation. Cell Rep 43:114332. https:\/\/doi.org\/10.1016\/j.celrep.2024.114332","journal-title":"Cell Rep"},{"key":"9022_CR117","doi-asserted-by":"publisher","unstructured":"Shah K, Leandro MJ, Cragg MS et al (2024) P179 CD19hi B cells express T-bet and display activated metabolism and function in rheumatoid arthritis and systemic lupus erythematosus patient samples. Rheumatology (Oxford) 63. https:\/\/doi.org\/10.1093\/rheumatology\/keae163.218","DOI":"10.1093\/rheumatology\/keae163.218"},{"key":"9022_CR118","doi-asserted-by":"publisher","first-page":"18164","DOI":"10.1038\/s41598-024-68660-9","volume":"14","author":"D Lee","year":"2024","unstructured":"Lee D, Jo MG, Min KY et al (2024) IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation. Sci Rep 14:18164. https:\/\/doi.org\/10.1038\/s41598-024-68660-9","journal-title":"Sci Rep"},{"key":"9022_CR119","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12879-024-09494-8","volume":"24","author":"LL Gois","year":"2024","unstructured":"Gois LL, Ribeiro-Soares B, Regis-Silva CG et al (2024) Imbalanced IL10\/TGF-\u03b2 production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy\/ tropical spastic paraparesis. BMC Infect Dis 24:652. https:\/\/doi.org\/10.1186\/s12879-024-09494-8","journal-title":"BMC Infect Dis"},{"key":"9022_CR120","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1038\/s41598-024-67912-y","volume":"14","author":"C Rival","year":"2024","unstructured":"Rival C, Mandal M, Cramton K, Qiao H, Arish M, Sun J et al (2024) B cells secrete functional antigen specific IgG antibodies on extracellular vesicles. Sci Rep 14:16970","journal-title":"Sci Rep"},{"key":"9022_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011957","volume":"20","author":"D Dolbec","year":"2024","unstructured":"Dolbec D, Lehoux M, de Beauville AA, Zahn A, Di Noia JM, Segura MJPP (2024) Unmutated but T cell dependent IgM antibodies targeting Streptococcus suis play an essential role in bacterial clearance. Plos Pathog 20:e1011957","journal-title":"Plos Pathog"},{"key":"9022_CR122","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tips.2024.07.007","volume":"45","author":"I Talucci","year":"2024","unstructured":"Talucci I, Maric HM (2024) Epitope landscape in autoimmune neurological disease and beyond. Trends Pharmacol Sci 45:768\u2013780. https:\/\/doi.org\/10.1016\/j.tips.2024.07.007","journal-title":"Trends Pharmacol Sci"},{"key":"9022_CR123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.13359","volume":"325","author":"A Lamba","year":"2024","unstructured":"Lamba A, Taneja V (2024) Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis. Immunol Rev 325:90\u2013106. https:\/\/doi.org\/10.1111\/imr.13359","journal-title":"Immunol Rev"},{"key":"9022_CR124","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1940-6207.CAPR-23-0395","volume":"17","author":"NA Borja","year":"2024","unstructured":"Borja NA, Silva-Smith R, Calfa C, Sussman DA, Tekin MJCPR (2024) Triple primary cancers: an analysis of genetic and environmental factors. Cancer Prev Res 17:209\u2013215","journal-title":"Cancer Prev Res"},{"key":"9022_CR125","doi-asserted-by":"publisher","first-page":"eadi3808","DOI":"10.1126\/science.adi3808","volume":"383","author":"C Krishna","year":"2024","unstructured":"Krishna C, Tervi A, Saffern M, Wilson EA, Yoo S-K, Mars N et al (2024) An immunogenetic basis for lung cancer risk. Science 383:eadi3808","journal-title":"Science"},{"key":"9022_CR126","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2024.01.030","volume":"167","author":"HJ Galipeau","year":"2024","unstructured":"Galipeau HJ, Hinterleitner R, Leonard MM, Caminero AJG (2024) Non-host factors influencing onset and severity of celiac disease. Gastroenterology 167:34\u201350","journal-title":"Gastroenterology"},{"key":"9022_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25005","volume":"38","author":"T Hoseinnezhad","year":"2024","unstructured":"Hoseinnezhad T, Soltani N, Ziarati S, Behboudi E, Mousavi MJJJOCLA (2024) The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: a global review. J Clin Lab Anal 38:e25005","journal-title":"J Clin Lab Anal"},{"key":"9022_CR128","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/cancers16030579","volume":"16","author":"V Valentini","year":"2024","unstructured":"Valentini V, Bucalo A, Conti G, Celli L, Porzio V, Capalbo C et al (2024) Gender-specific genetic predisposition to breast cancer: BRCA genes and beyond. Cancers 16:579","journal-title":"Cancers"},{"key":"9022_CR129","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jiph.2024.02.001","volume":"17","author":"M Kanan","year":"2024","unstructured":"Kanan M, Naffaa M, Alanazi A et al (2024) Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis. J Infect Public Health 17:579\u2013587. https:\/\/doi.org\/10.1016\/j.jiph.2024.02.001","journal-title":"J Infect Public Health"},{"key":"9022_CR130","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/biomedicines12030616","volume":"12","author":"S Martinelli","year":"2024","unstructured":"Martinelli S, Nannini G, Cianchi F, Coratti F, Amedei AJB (2024) The impact of microbiota\u2013immunity\u2013hormone interactions on autoimmune diseases and infection. Biomedicines 12:616","journal-title":"Biomedicines"},{"key":"9022_CR131","doi-asserted-by":"publisher","first-page":"1361123","DOI":"10.3389\/fimmu.2024.1361123","volume":"15","author":"A Ohashi","year":"2024","unstructured":"Ohashi A, Murayama MA, Miyabe Y, Yudoh K, Miyabe CJFII (2024) Streptococcal infection and autoimmune diseases. Front Immunol 15:1361123","journal-title":"Front Immunol"},{"key":"9022_CR132","doi-asserted-by":"publisher","first-page":"1374796","DOI":"10.3389\/fimmu.2024.1374796","volume":"15","author":"DN Di Florio","year":"2024","unstructured":"Di Florio DN, Beetler DJ, McCabe EJ, Sin J, Ikezu T, Fairweather DJFII (2024) Mitochondrial extracellular vesicles, autoimmunity and myocarditis. Front Immunol 15:1374796","journal-title":"Front Immunol"},{"key":"9022_CR133","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/ijms25021019","volume":"25","author":"Y Araki","year":"2024","unstructured":"Araki Y, Mimura TJIJOMS (2024) Epigenetic dysregulation in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci 25:1019","journal-title":"Int J Mol Sci"},{"key":"9022_CR134","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1111\/febs.17116","volume":"291","author":"LM Merlo Pich","year":"2024","unstructured":"Merlo Pich LM, Ziogas A, Netea MG (2024) Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases. FEBS J 291:4414\u20134432. https:\/\/doi.org\/10.1111\/febs.17116","journal-title":"FEBS J"},{"key":"9022_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115329","volume":"210","author":"CT Smith","year":"2024","unstructured":"Smith CT, Wang Z, Lewis JS (2024) Engineering antigen-presenting cells for immunotherapy of autoimmunity. Adv Drug Deliv Rev 210:115329. https:\/\/doi.org\/10.1016\/j.addr.2024.115329","journal-title":"Adv Drug Deliv Rev"},{"key":"9022_CR136","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1021\/acsnano.3c10180","volume":"18","author":"F Hou","year":"2024","unstructured":"Hou F, Guo Z, Ho MT, Hui Y, Zhao C-XJAN (2024) Particle-based artificial antigen-presenting cell systems for T cell activation in adoptive T cell therapy. ACS Nano 18:8571\u20138599","journal-title":"ACS Nano"},{"key":"9022_CR137","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/biom14091161","volume":"14","author":"W Li","year":"2024","unstructured":"Li W, Chen G, Peng H et al (2024) Research progress on dendritic cells in hepatocellular carcinoma immune microenvironments. Biomolecules 14:1161. https:\/\/doi.org\/10.3390\/biom14091161","journal-title":"Biomolecules"},{"key":"9022_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101940","volume":"38","author":"B Cai","year":"2024","unstructured":"Cai B, Thomas R (2024) Dendritic cells and antigen-specific immunotherapy in autoimmune rheumatic diseases. Best Pract Res Clin Rheumatol 38:101940. https:\/\/doi.org\/10.1016\/j.berh.2024.101940","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"9022_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41420-023-01782-7","volume":"10","author":"D Qian","year":"2024","unstructured":"Qian D, Liu Y, Zheng J, Cai JJCDD (2024) Dendritic cell therapy for neurospoagioma: immunomodulation mediated by tumor vaccine. Cell Death Discov 10:11","journal-title":"Cell Death Discov"},{"key":"9022_CR140","doi-asserted-by":"publisher","first-page":"1422834","DOI":"10.3389\/fimmu.2024.1422834","volume":"15","author":"T Arumugam","year":"2024","unstructured":"Arumugam T, Adimulam T, Gokul A, Ramsuran VJFII (2024) Variation within the non-coding genome influences genetic and epigenetic regulation of the human leukocyte antigen genes. Front Immunol 15:1422834","journal-title":"Front Immunol"},{"key":"9022_CR141","doi-asserted-by":"publisher","unstructured":"Jawale D, Khandibharad S, Singh S (2024) Innate immune response and epigenetic regulation: a closely intertwined tale in inflammation. Adv Biol (Weinh). https:\/\/doi.org\/10.1002\/adbi.202400278","DOI":"10.1002\/adbi.202400278"},{"key":"9022_CR142","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.3390\/cimb46070441","volume":"46","author":"C Cucoreanu","year":"2024","unstructured":"Cucoreanu C, Tigu A-B, Nistor M, Moldovan R-C, Pralea I-E, Iacobescu M et al (2024) Epigenetic and molecular alterations in obesity: linking CRP and DNA methylation to systemic inflammation. Curr Issues Mol Biol 46:7430","journal-title":"Curr Issues Mol Biol"},{"key":"9022_CR143","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/2159-8290.CD-23-1091","volume":"14","author":"C Cobaleda","year":"2024","unstructured":"Cobaleda C, Godley LA, Nichols KE, Wlodarski MW, Sanchez-Garcia IJCD (2024) Insights into the molecular mechanisms of genetic predisposition to hematopoietic malignancies: the importance of gene\u2013environment interactions. Cancer Discov 14:396\u2013405","journal-title":"Cancer Discov"},{"key":"9022_CR144","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/ijms25158160","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C et al (2024) Epstein-Barr viruses: their immune evasion strategies and implications for autoimmune diseases. Int J Mol Sci 25:8160","journal-title":"Int J Mol Sci"},{"key":"9022_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.115212","volume":"476","author":"NA Althobaiti","year":"2025","unstructured":"Althobaiti NA (2025) Heavy metals exposure and Alzheimer\u2019s disease: underlying mechanisms and advancing therapeutic approaches. Behav Brain Res 476:115212. https:\/\/doi.org\/10.1016\/j.bbr.2024.115212","journal-title":"Behav Brain Res"},{"key":"9022_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2024.200286","volume":"38","author":"D Menafra","year":"2024","unstructured":"Menafra D, Progan\u00f2 M, Tecce N et al (2024) Diet and gut microbiome: Impact of each factor and mutual interactions on prevention and treatment of type 1, type 2, and gestational diabetes mellitus. Hum Nutr Metab 38:200286. https:\/\/doi.org\/10.1016\/j.hnm.2024.200286","journal-title":"Hum Nutr Metab"},{"key":"9022_CR147","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1080\/10408398.2022.2160962","volume":"64","author":"J Shi","year":"2024","unstructured":"Shi J, Wang Y, Cheng L, Wang J (2024) Raghavan VJCRIFS (2024) Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment. Crit Rev Food Sci Nutr 64:5984\u20136000","journal-title":"Crit Rev Food Sci Nutr"},{"key":"9022_CR148","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-024-01633-x","volume":"16","author":"D Zhu","year":"2024","unstructured":"Zhu D, Zeng S, Su C, Li J, Xuan Y, Lin Y et al (2024) The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications. Clin Epigenetics 16:24","journal-title":"Clin Epigenetics"},{"key":"9022_CR149","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/cac2.12546","volume":"44","author":"Y Tang","year":"2024","unstructured":"Tang Y, Cui G, Liu H et al (2024) Converting \u201ccold\u201d to \u201chot\u201d: epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells. Cancer Commun (Lond) 44:601\u2013636. https:\/\/doi.org\/10.1002\/cac2.12546","journal-title":"Cancer Commun (Lond)"},{"key":"9022_CR150","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/14728222.2024.2375372","volume":"28","author":"Z-X Gao","year":"2024","unstructured":"Gao Z-X, He T, Zhang P, Hu X, Ge M, Xu Y-Q et al (2024) Epigenetic regulation of immune cells in systemic lupus erythematosus: insight from chromatin accessibility. Expert Opin Ther Targets 28:637\u2013649","journal-title":"Expert Opin Ther Targets"},{"key":"9022_CR151","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10557-022-07422-z","volume":"38","author":"P Swiatlowska","year":"2024","unstructured":"Swiatlowska P, Iskratsch TJCD (2024) Cardiovascular mechano-epigenetics: force-dependent regulation of histone modifications and gene regulation. Cardiovasc Drugs Ther 38:215\u2013222","journal-title":"Cardiovasc Drugs Ther"},{"key":"9022_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156585","volume":"179","author":"S Khalilollah","year":"2024","unstructured":"Khalilollah S, Soltanieh SK, Saleh RO, Alzahrani AA, Maabreh HG, Al-Hamdani MM et al (2024) LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review. Cytokine 179:156585","journal-title":"Cytokine"},{"key":"9022_CR153","doi-asserted-by":"publisher","unstructured":"Ding G, Yang X, Li Y et al (2024) Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-024-05077-y","DOI":"10.1007\/s11010-024-05077-y"},{"key":"9022_CR154","doi-asserted-by":"publisher","unstructured":"Lozano Chinga MM, Bussel JB, Fluchel MN et al (2024) Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome. Pediatr Blood Cancer 71. https:\/\/doi.org\/10.1002\/pbc.31239","DOI":"10.1002\/pbc.31239"},{"key":"9022_CR155","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-981-99-9781-7_15","volume":"1444","author":"H Yoshida","year":"2024","unstructured":"Yoshida H (2024) Dissecting the immune system through gene regulation. Adv Exp Med Biol 1444:219\u2013235. https:\/\/doi.org\/10.1007\/978-981-99-9781-7_15","journal-title":"Adv Exp Med Biol"},{"key":"9022_CR156","doi-asserted-by":"publisher","unstructured":"Greco L, Auricchio R (2024) Genetic predisposition. In: Pediatric and adult celiac disease. Elsevier, pp 25\u201340. https:\/\/doi.org\/10.1016\/B978-0-443-13359-6.00020-0","DOI":"10.1016\/B978-0-443-13359-6.00020-0"},{"key":"9022_CR157","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/iub.2794","volume":"76","author":"G Joshi","year":"2024","unstructured":"Joshi G, Das A, Verma G, Guchhait PJIL (2024) Viral infection and host immune response in diabetes. IUBMB Life 76:242\u2013266","journal-title":"IUBMB Life"},{"key":"9022_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152558","volume":"69","author":"M Ploesser","year":"2024","unstructured":"Ploesser M, Silverman S, Diaz JDL et al (2024) The link between traumatic stress and autoimmune rheumatic diseases: A systematic scoping review. Semin Arthritis Rheum 69:152558. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152558","journal-title":"Semin Arthritis Rheum"},{"key":"9022_CR159","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/healthcare12171767","volume":"12","author":"A Mpakosi","year":"2024","unstructured":"Mpakosi A, Cholevas V, Tzouvelekis I et al (2024) Autoimmune diseases following environmental disasters: a narrative review of the literature. Healthcare (Basel) 12:1767. https:\/\/doi.org\/10.3390\/healthcare12171767","journal-title":"Healthcare (Basel)"},{"key":"9022_CR160","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.toxrep.2024.04.010","volume":"12","author":"PI Adegbola","year":"2024","unstructured":"Adegbola PI, Adetutu A (2024) Genetic and epigenetic modulations in toxicity: the two-sided roles of heavy metals and polycyclic aromatic hydrocarbons from the environment. Toxicol Rep 12:502\u2013519. https:\/\/doi.org\/10.1016\/j.toxrep.2024.04.010","journal-title":"Toxicol Rep"},{"key":"9022_CR161","doi-asserted-by":"publisher","unstructured":"de Punder K, Karabatsiakis A (2024) Age-related disease: immune system. In: Aging. Elsevier, pp 119\u2013145. https:\/\/doi.org\/10.1016\/B978-0-443-15500-0.00004-9","DOI":"10.1016\/B978-0-443-15500-0.00004-9"},{"key":"9022_CR162","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.3390\/ijms25147554","volume":"25","author":"F Hernandez-Gonzalez","year":"2024","unstructured":"Hernandez-Gonzalez F, Pietrocola F, Cameli P, Bargagli E, Prieto-Gonz\u00e1lez S, Cruz T et al (2024) Exploring the interplay between cellular senescence, immunity, and fibrosing interstitial lung diseases: challenges and opportunities. Int J Mol Sci 25:7554","journal-title":"Int J Mol Sci"},{"key":"9022_CR163","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/medicina60010110","volume":"60","author":"S Mija\u010d","year":"2024","unstructured":"Mija\u010d S, Bani\u0107 I, Genc A-M, Lipej M, Turkalj MJM (2024) The effects of environmental exposure on epigenetic modifications in allergic diseases. Medicina 60:110","journal-title":"Medicina"},{"key":"9022_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27700","volume":"10","author":"LM Trefilio","year":"2024","unstructured":"Trefilio LM, Bottino L, de Carvalho CR et al (2024) The impact of genetic variants related to vitamin D and autoimmunity: a systematic review. Heliyon 10:e27700. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27700","journal-title":"Heliyon"},{"key":"9022_CR165","doi-asserted-by":"publisher","unstructured":"Sharif K, Amital H (2024) Heavy metals in autoimmune diseases: too much noise in autoimmunity. Autoimmune Dis 201\u2013223. https:\/\/doi.org\/10.1002\/9781119858430.ch19","DOI":"10.1002\/9781119858430.ch19"},{"key":"9022_CR166","doi-asserted-by":"publisher","unstructured":"Samsing F, Barnes AC (2024) The rise of the opportunists: what are the drivers of the increase in infectious diseases caused by environmental and commensal bacteria? Rev Aquac 16(4). https:\/\/doi.org\/10.1111\/raq.12922","DOI":"10.1111\/raq.12922"},{"key":"9022_CR167","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41569-023-00931-w","volume":"21","author":"H Janssen","year":"2024","unstructured":"Janssen H, Koekkoek LL, Swirski FK (2024) Effects of lifestyle factors on leukocytes in cardiovascular health and disease. Nat Rev Cardiol 21:157\u2013169","journal-title":"Nat Rev Cardiol"},{"key":"9022_CR168","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-981-97-0130-8_16","volume-title":"Sex\/gender-specific medicine in clinical areas","author":"SM Moon","year":"2024","unstructured":"Moon SM (2024) Sex\/gender differences in infectious diseases. In: Sex\/gender-specific medicine in clinical areas. Springer, pp 311\u2013324. https:\/\/doi.org\/10.1007\/978-981-97-0130-8_16"},{"key":"9022_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.joclim.2024.100338","volume":"19","author":"TR Katsumoto","year":"2024","unstructured":"Katsumoto TR, Stolyar L, Dandeniya CL et al (2024) Impact of climate change on rheumatic diseases: a scoping review. J Clim Chang Health 19:100338. https:\/\/doi.org\/10.1016\/j.joclim.2024.100338","journal-title":"J Clim Chang Health"},{"key":"9022_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105653","volume":"161","author":"GAW Rook","year":"2024","unstructured":"Rook GAW (2024) Evolution and the critical role of the microbiota in the reduced mental and physical health associated with low socioeconomic status (SES). Neurosci Biobehav Rev 161:105653. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105653","journal-title":"Neurosci Biobehav Rev"},{"key":"9022_CR171","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/C2023-0-01338-3","volume-title":"The Rose and Mackay textbook of autoimmune diseases","author":"CA Wagner","year":"2024","unstructured":"Wagner CA, Smith K, James JA, James EA (2024) Triggers for autoimmunity. In: The Rose and Mackay textbook of autoimmune diseases. Elsevier, pp 103\u2013121. https:\/\/doi.org\/10.1016\/C2023-0-01338-3"},{"key":"9022_CR172","doi-asserted-by":"publisher","first-page":"01","DOI":"10.55640\/ijmsdh-10-03-18","volume":"10","author":"EH Abd Ali","year":"2024","unstructured":"Abd Ali EH, Mohammed HO (2024) Autoimmune disorders unraveled: the interplay between genetics and the immune system. Int J Med Sci Dent Health 10:01\u201314","journal-title":"Int J Med Sci Dent Health"},{"key":"9022_CR173","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1124\/pharmrev.123.001084","volume":"76","author":"Z Huang","year":"2024","unstructured":"Huang Z, Braunstein Z, Chen J, Wei Y, Rao X, Dong L et al (2024) Precision medicine in rheumatic diseases: unlocking the potential of antibody-drug conjugates. Pharmacol Rev 76:579\u2013598","journal-title":"Pharmacol Rev"},{"key":"9022_CR174","doi-asserted-by":"publisher","first-page":"1326281","DOI":"10.3389\/fphar.2023.1326281","volume":"14","author":"X-H Wei","year":"2024","unstructured":"Wei X-H, Liu Y-YJFIP (2024) Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy. Front Pharmacol 14:1326281","journal-title":"Front Pharmacol"},{"key":"9022_CR175","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000535647","volume":"42","author":"A Sokic-Milutinovic","year":"2024","unstructured":"Sokic-Milutinovic A, Milosavljevic T (2024) Inflammatory bowel disease: from conventional immunosuppression to biologic therapy. Dig Dis 42:325\u2013335","journal-title":"Dig Dis"},{"key":"9022_CR176","doi-asserted-by":"publisher","first-page":"1404191","DOI":"10.3389\/fimmu.2024.1404191","volume":"15","author":"P Cavalcante","year":"2024","unstructured":"Cavalcante P, Mantegazza R, Antozzi CJFII (2024) Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis. Front Immunol 15:1404191","journal-title":"Front Immunol"},{"key":"9022_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112189","volume":"134","author":"B Sun","year":"2024","unstructured":"Sun B, Shen K, Zhao R, Li Y, Xiang M, Lin JJII (2024) Precision medicine for severe asthma\u2013biological targeted therapy. Int Immunopharmacol 134:112189","journal-title":"Int Immunopharmacol"},{"key":"9022_CR178","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/oarrr.s372610","volume":"16","author":"S Sharma","year":"2024","unstructured":"Sharma S, Bluett J (2024) Towards personalized medicine in rheumatoid arthritis. Open Access Rheumatol 16:89\u2013114. https:\/\/doi.org\/10.2147\/oarrr.s372610","journal-title":"Open Access Rheumatol"},{"key":"9022_CR179","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejim.2024.05.011","volume":"125","author":"G Varricchi","year":"2024","unstructured":"Varricchi G, Poto RJEJOIM (2024) Towards precision medicine in COPD: targeting type 2 cytokines and alarmins. Eur J Intern Med 125:28\u201331","journal-title":"Eur J Intern Med"},{"key":"9022_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124211","volume":"659","author":"S Parit","year":"2024","unstructured":"Parit S, Manchare A, Gholap AD, Mundhe P, Hatvate N, Rojekar S et al (2024) Antibody-drug conjugates: a promising breakthrough in cancer therapy. Int J Pharm 659:124211","journal-title":"Int J Pharm"},{"key":"9022_CR181","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41419-024-06837-w","volume":"15","author":"P Yu","year":"2024","unstructured":"Yu P, Zhu C, You X, Gu W, Wang X, Wang Y et al (2024) The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies. Cell DeathDis 15:433","journal-title":"Cell DeathDis"},{"key":"9022_CR182","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/pharmaceutics16091146","volume":"16","author":"A Pinto","year":"2024","unstructured":"Pinto A, Guarini C, Giampaglia M et al (2024) Synergizing immunotherapy and antibody\u2013drug conjugates: new horizons in breast cancer therapy. Pharmaceutics 16:1146. https:\/\/doi.org\/10.3390\/pharmaceutics16091146","journal-title":"Pharmaceutics"},{"issue":"2","key":"9022_CR183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.26641\/2307-0404.2024.2.307587","volume":"29","author":"M Lisiecka","year":"2024","unstructured":"Lisiecka M (2024) Side effects and hypersensitivity reactions to corticosteroids. Medical Perspectives \/ Medi\u010dn\u00ec Perspektivi 29(2):95. https:\/\/doi.org\/10.26641\/2307-0404.2024.2.307587","journal-title":"Medical Perspectives \/ Medi\u010dn\u00ec Perspektivi"},{"key":"9022_CR184","doi-asserted-by":"publisher","first-page":"1447337","DOI":"10.3389\/fimmu.2024.1447337","volume":"15","author":"ZJFII Elkoshi","year":"2024","unstructured":"Elkoshi ZJFII (2024) Autoimmune diseases refractory to corticosteroids and immunosuppressants. Front Immunol 15:1447337","journal-title":"Front Immunol"},{"key":"9022_CR185","first-page":"400","volume":"22","author":"DD Kanatoula","year":"2024","unstructured":"Kanatoula DD, Bodner E, Ghoreschi K, Meier K, Solimani F (2024) Non-biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases. JDDG: J Dtsch Dermatologischen Ges 22:400\u2013421","journal-title":"JDDG: J Dtsch Dermatologischen Ges"},{"key":"9022_CR186","doi-asserted-by":"publisher","unstructured":"Aftab I, Ginzler EM, Dvorkina O (2025) Immunosuppressive drug therapy. In: Dubois\u02bc lupus erythematosus and related syndromes. Elsevier, pp 763\u201376. e1. https:\/\/doi.org\/10.1016\/C2015-0-06776-4","DOI":"10.1016\/C2015-0-06776-4"},{"key":"9022_CR187","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/cpt.3288","volume":"116","author":"A Al-Khouja","year":"2024","unstructured":"Al-Khouja A, Chaudhri N, Velidedeoglu E et al (2024) Approval of mycophenolate mofetil for prophylaxis of organ rejection in pediatric recipients of heart or liver transplants: A regulatory perspective. Clin Pharmacol Ther 116:807\u2013813. https:\/\/doi.org\/10.1002\/cpt.3288","journal-title":"Clin Pharmacol Ther"},{"key":"9022_CR188","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00415-023-12007-3","volume":"271","author":"SR Delgado","year":"2024","unstructured":"Delgado SR, Faissner S, Linker RA, Rammohan K (2024) Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment. J Neurol 271:1515\u20131535","journal-title":"J Neurol"},{"key":"9022_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2024.06.001","volume":"78","author":"L Neurath","year":"2024","unstructured":"Neurath L, Sticherling M, Schett G, Fagni F (2024) Targeting cytokines in psoriatic arthritis. Cytokine Growth Factor Rev 78:1\u201313. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.06.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"9022_CR190","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.3390\/ijms25158327","volume":"25","author":"K Kie\u0142bowski","year":"2024","unstructured":"Kie\u0142bowski K, Plewa P, Bratborska AW, Bakinowska E, Pawlik A (2024) JAK Inhibitors in rheumatoid arthritis: immunomodulatory properties and clinical efficacy. Int J Mol Sci 25:8327","journal-title":"Int J Mol Sci"},{"key":"9022_CR191","doi-asserted-by":"publisher","unstructured":"Lino AC, D\u00f6rner T (2024) Therapeutic targeting of B cells and plasma cells with a focus on multiple sclerosis and other autoimmune conditions. In: Molecular biology of B cells. Elsevier, pp 425\u2013435. https:\/\/doi.org\/10.1016\/b978-0-323-95895-0.00007-6","DOI":"10.1016\/b978-0-323-95895-0.00007-6"},{"key":"9022_CR192","doi-asserted-by":"publisher","first-page":"189","DOI":"10.37349\/ei.2024.00136","volume":"4","author":"M El Jamal","year":"2024","unstructured":"El Jamal M, Shibli F (2024) Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies. Explor Immunol 4:189\u2013210","journal-title":"Explor Immunol"},{"key":"9022_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2024.100297","volume":"4","author":"A Blauvelt","year":"2024","unstructured":"Blauvelt A, Chen Y, Branigan PJ, Liu X, DePrimo S, Keyes BE et al (2024) Differential pharmacodynamic effects on psoriatic biomarkers by guselkumab versus secukinumab correlate with long-term efficacy: an ECLIPSE substudy. JID Innovations 4:100297","journal-title":"JID Innovations"},{"key":"9022_CR194","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s13555-024-01122-2","volume":"14","author":"R Sun","year":"2024","unstructured":"Sun R, Bustamante M, Gurusamy VK, Lebwohl M, Gottlieb AB, Mease PJ et al (2024) Safety of secukinumab from 1 million patient-years of exposure: experience from post-marketing setting and clinical trials. Dermatol Ther 14:729\u2013743","journal-title":"Dermatol Ther"},{"key":"9022_CR195","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40272-023-00615-5","volume":"26","author":"K Cetin Gedik","year":"2024","unstructured":"Cetin Gedik K, Arici ZS, Kul Cinar O, Garcia-Bournissen F, Romano M, Demirkaya EJPD (2024) Practical approach to diagnosis and management of IL-1-mediated autoinflammatory diseases (CAPS, TRAPS, MKD, and DIRA). Pediatr Drugs 26:113\u2013126","journal-title":"Pediatr Drugs"},{"key":"9022_CR196","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40259-023-00634-1","volume":"38","author":"AB Avci","year":"2024","unstructured":"Avci AB, Feist E, Burmester GR (2024) Targeting IL-6 or IL-6 receptor in rheumatoid arthritis: what have we learned? BioDrugs 38:61\u201371","journal-title":"BioDrugs"},{"key":"9022_CR197","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/1744666X.2023.2250918","volume":"20","author":"L Rusi\u00f1ol","year":"2024","unstructured":"Rusi\u00f1ol L, Carmona-Rocha E, Puig L (2024) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Rev Clin Immunol 20:71\u201382","journal-title":"Expert Rev Clin Immunol"},{"key":"9022_CR198","first-page":"1373","volume":"109","author":"S De Coninck","year":"2024","unstructured":"De Coninck S, De Smedt R, Lintermans B, Reunes L, Kosasih HJ, Reekmans A et al (2024) Targeting hyperactive platelet-derived growth factor receptor-\u03b2 signaling in T-cell acute lymphoblastic leukemia and lymphoma. Haematologica 109:1373","journal-title":"Haematologica"},{"key":"9022_CR199","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12890-024-02885-2","volume":"24","author":"W Li","year":"2024","unstructured":"Li W, Tang S-C, Jin L (2024) Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments. BMC Pulm Med 24:70","journal-title":"BMC Pulm Med"},{"key":"9022_CR200","first-page":"141","volume":"15: (01)","author":"A Brown","year":"2024","unstructured":"Brown A (2024) Precision medicine in oncology: targeted therapies and genetic profiling. 15:(01):141\u2013151. https:\/\/ijmlrcai.com\/index.php\/Journal\/index","journal-title":"Precision medicine in oncology: targeted therapies and genetic profiling"},{"key":"9022_CR201","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3390\/diagnostics14131448","volume":"14","author":"A Krsek","year":"2024","unstructured":"Krsek A, Baticic L, Sotosek V, Braut T (2024) The role of biomarkers in HPV-positive head and neck squamous cell carcinoma: towards precision medicine. Diagnostics (Basel) 14:1448. https:\/\/doi.org\/10.3390\/diagnostics14131448","journal-title":"Diagnostics (Basel)"},{"key":"9022_CR202","doi-asserted-by":"publisher","unstructured":"Zeng Z, Yang A, Yang J et al (2024) Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study. Signal Transduct Target Ther 9. https:\/\/doi.org\/10.1038\/s41392-024-01941-x","DOI":"10.1038\/s41392-024-01941-x"},{"key":"9022_CR203","doi-asserted-by":"publisher","unstructured":"Rusnak-Kaushanska OV, Antoniv AA, Kotsiubiichuk ZY (2024) Use of the disease-modifying drug leflunomide in patients with rheumatoid arthritis. Health Educ 3\u20138. https:\/\/doi.org\/10.32782\/health-2024.2.1","DOI":"10.32782\/health-2024.2.1"},{"key":"9022_CR204","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.3390\/jcm13185404","volume":"13","author":"MC Ugur","year":"2024","unstructured":"Ugur MC, Baysal M, Umit EG (2024) The role of thalidomide and its analogs in the treatment of hereditary hemorrhagic telangiectasia: a systematic review. J Clin Med 13:5404","journal-title":"J Clin Med"},{"key":"9022_CR205","doi-asserted-by":"publisher","unstructured":"Hoenigl M, Arastehfar A, Arendrup MC et al (2024) Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. Clin Microbiol Rev 37. https:\/\/doi.org\/10.1128\/cmr.00074-23","DOI":"10.1128\/cmr.00074-23"},{"key":"9022_CR206","first-page":"183","volume-title":"In","author":"GJ Mantzaris","year":"2024","unstructured":"Mantzaris GJ (2024) Calcineurin Inhibitors (cyclosporine A, tacrolimus, and sirolimus) and mycophenolate mofetil in Crohn\u02bcs disease. In: Crohn's disease. CRC Press, pp 183\u2013195"},{"key":"9022_CR207","doi-asserted-by":"publisher","first-page":"1520083","DOI":"10.3389\/fimmu.2024.1520083","volume":"15","author":"D Kong","year":"2025","unstructured":"Kong D, Duan J, Chen S, Wang Z, Ren J, Lu J, Chen T, Song Z, Wu D, Chang Y, Yin Z (2025) Transplant oncology and anti-cancer immunosuppressants. Front Immunol 15:1520083","journal-title":"Front Immunol"},{"key":"9022_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26971","volume":"10","author":"R Deyhimfar","year":"2024","unstructured":"Deyhimfar R, Izady M, Shoghi M et al (2024) The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases. Heliyon 10:e26971. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26971","journal-title":"Heliyon"},{"key":"9022_CR209","doi-asserted-by":"publisher","first-page":"4","DOI":"10.47093\/2218-7332.2024.15.1.4-19","volume":"15","author":"MA Peshkova","year":"2024","unstructured":"Peshkova MA, Korneev A, Koteneva PI, Kosheleva NV, Timashev PS (2024) Prospects for microbiome modulation in autoimmune diseases: a literature review. Sechenov Med J 15:4\u201319","journal-title":"Sechenov Med J"},{"key":"9022_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101863","volume":"80","author":"M Chrudinov\u00e1","year":"2024","unstructured":"Chrudinov\u00e1 M, Kirk NS, Chuard A, Venugopal H, Zhang F, Lubos M et al (2024) A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression. Mol Metab 80:101863","journal-title":"Mol Metab"},{"key":"9022_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102476","volume":"69","author":"R Greco","year":"2024","unstructured":"Greco R, Alexander T, Del Papa N et al (2024) Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. EClinicalMedicine 69:102476. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102476","journal-title":"EClinicalMedicine"},{"key":"9022_CR212","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-bioeng-110122-014306","volume":"26","author":"AB Tu","year":"2024","unstructured":"Tu AB, Krishna G, Smith KR, Lewis JS (2024) Harnessing immunomodulatory polymers for treatment of autoimmunity, allergy, and transplant rejection. Ann Rev Biomed Eng 26:415\u2013440","journal-title":"Ann Rev Biomed Eng"},{"key":"9022_CR213","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038088","volume":"103","author":"OP-C Ugwu","year":"2024","unstructured":"Ugwu OP-C, Alum EU, Okon MB, Obeagu EI (2024) Mechanisms of microbiota modulation: implications for health, disease, and therapeutic interventions. Medicine 103:e38088","journal-title":"Medicine"},{"key":"9022_CR214","doi-asserted-by":"publisher","unstructured":"Musa DA, Raji MO, Sikiru AB et al (2024) Promising RNA-based therapies for Viral infections, genetic disorders and cancer. Academia Mol Biol Genom. https:\/\/doi.org\/10.20935\/acadmolbiogen7329","DOI":"10.20935\/acadmolbiogen7329"},{"key":"9022_CR215","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2174\/0113892010291042240130171709","volume":"25","author":"A Goel","year":"2024","unstructured":"Goel A, Rastogi A, Jain M, Niveriya K (2024) RNA-based therapeutics: Past, present and future prospects, challenges in cancer treatment. Curr Pharm Biotechnol 25:2125\u20132137. https:\/\/doi.org\/10.2174\/0113892010291042240130171709","journal-title":"Curr Pharm Biotechnol"},{"key":"9022_CR216","doi-asserted-by":"publisher","unstructured":"Attia MS, Kijanka G, Nguyen N-T et al (2024) Advances and prospects of RNA delivery nanoplatforms for cancer therapy. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2024.09.009","DOI":"10.1016\/j.apsb.2024.09.009"},{"key":"9022_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101555","volume":"5","author":"PE Saw","year":"2024","unstructured":"Saw PE, Song E (2024) Advancements in clinical RNA therapeutics: present developments and prospective outlooks. Cell Rep Med 5:101555. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101555","journal-title":"Cell Rep Med"},{"key":"9022_CR218","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2147\/dddt.s447780","volume":"18","author":"Z-C Lin","year":"2024","unstructured":"Lin Z-C, Hung C-F, Aljuffali IA et al (2024) RNA-based antipsoriatic gene therapy: an updated review focusing on evidence from animal models. Drug Des Devel Ther 18:1277\u20131296. https:\/\/doi.org\/10.2147\/dddt.s447780","journal-title":"Drug Des Devel Ther"},{"key":"9022_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102519","volume":"101","author":"AM Sivalingam","year":"2024","unstructured":"Sivalingam AM (2024) Advances in understanding biomarkers and treating neurological diseases \u2013 role of the cerebellar dysfunction and emerging therapies. Ageing Res Rev 101:102519","journal-title":"Ageing Res Rev"},{"key":"9022_CR220","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.7150\/ijbs.93697","volume":"20","author":"R Birnboim-Perach","year":"2024","unstructured":"Birnboim-Perach R, Benhar I (2024) Using combination therapy to overcome diverse challenges of immune checkpoint inhibitors treatment. Int J Biol Sci 20:3911","journal-title":"Int J Biol Sci"},{"key":"9022_CR221","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12951-024-02670-7","volume":"22","author":"S Ren","year":"2024","unstructured":"Ren S, Xu Y, Dong X, Mu Q, Chen X, Yu Y et al (2024) Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges. J Nanobiotechnol 22:431","journal-title":"J Nanobiotechnol"},{"key":"9022_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122499","volume":"341","author":"AF Khafaga","year":"2024","unstructured":"Khafaga AF, Gaballa MMS, Karam R et al (2024) Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer. Life Sci 341:122499. https:\/\/doi.org\/10.1016\/j.lfs.2024.122499","journal-title":"Life Sci"},{"key":"9022_CR223","doi-asserted-by":"publisher","first-page":"1364742","DOI":"10.3389\/fgene.2024.1364742","volume":"15","author":"M-L Zhang","year":"2024","unstructured":"Zhang M-L, Li H-B, Jin Y (2024) Application and perspective of CRISPR\/Cas9 genome editing technology in human diseases modeling and gene therapy. Front Genet 15:1364742","journal-title":"Front Genet"},{"key":"9022_CR224","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-323-90242-7.00015-8","volume":"202","author":"M Santana-Gon\u00e7alves","year":"2024","unstructured":"Santana-Gon\u00e7alves M, Malmegrim K, Farge D, Oliveira MC (2024) Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation. Handb Clin Neurol 202:75\u201391","journal-title":"Handb Clin Neurol"},{"key":"9022_CR225","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-981-97-2596-0_16","volume-title":"Biosystems, biomedical & drug delivery systems: characterization, restoration and optimization","author":"AB Kumbhar","year":"2024","unstructured":"Kumbhar AB, Nerkar NV, Phuge AN (2024) Regenerative medicines: application to degenerative diseases and disorders. In: Biosystems, biomedical & drug delivery systems: characterization, restoration and optimization. Springer, pp 345\u2013370. https:\/\/doi.org\/10.1007\/978-981-97-2596-0_16"},{"key":"9022_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115395","volume":"212","author":"KM Kim","year":"2024","unstructured":"Kim KM, D\u2019Elia AM, Rodell CB (2024) Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease. Adv Drug Deliv Rev 212:115395. https:\/\/doi.org\/10.1016\/j.addr.2024.115395","journal-title":"Adv Drug Deliv Rev"},{"key":"9022_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189183","volume":"1879","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qin C, Lin C et al (2024) Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: molecular mechanisms and therapeutic targets. Biochim Biophys Acta Rev Cancer 1879:189183. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189183","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"9022_CR228","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41584-024-01139-z","volume":"20","author":"G Schett","year":"2024","unstructured":"Schett G, M\u00fcller F, Taubmann J et al (2024) Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nat Rev Rheumatol 20:531\u2013544. https:\/\/doi.org\/10.1038\/s41584-024-01139-z","journal-title":"Nat Rev Rheumatol"},{"key":"9022_CR229","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"K Elumalai","year":"2024","unstructured":"Elumalai K, Srinivasan S, Shanmugam A (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedl Technol 5:109\u2013122","journal-title":"Biomedl Technol"},{"key":"9022_CR230","doi-asserted-by":"publisher","unstructured":"Vahidi M, Rizkalla AS, Mequanint K (2024) Extracellular matrix-surrogate advanced functional composite biomaterials for tissue repair and regeneration. Adv Healthc Mater 13(27):e2401218. https:\/\/doi.org\/10.1002\/adhm.202401218","DOI":"10.1002\/adhm.202401218"},{"key":"9022_CR231","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/pharmaceutics16091181","volume":"16","author":"R Hoshi","year":"2024","unstructured":"Hoshi R, Gorospe KA, Labouta HI, Azad T, Lee WL, Thu KL (2024) Alternative strategies for delivering immunotherapeutics targeting the PD-1\/PD-L1 immune checkpoint in cancer. Pharmaceutics 16:1181","journal-title":"Pharmaceutics"},{"key":"9022_CR232","first-page":"172","volume":"13","author":"TJ Dweh","year":"2024","unstructured":"Dweh TJ, Pattnaik S, Arshad T, Choudhury N (2024) MicroRNA as potential therapeutic targets to improve immunotherapy. Bull Env Pharmacol Life Sci 13:172\u2013179","journal-title":"Bull Env Pharmacol Life Sci"},{"key":"9022_CR233","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1567201819666220613150814","volume":"21","author":"ZY Guo","year":"2024","unstructured":"Guo ZY, Tang Y, Cheng YC (2024) Exosomes as targeted delivery drug system: advances in exosome loading, surface functionalization and potential for clinical application. Curr Drug Deliv 21:473\u2013487","journal-title":"Curr Drug Deliv"},{"key":"9022_CR234","doi-asserted-by":"publisher","unstructured":"Li J, Zhu J, Yang H, Hou F (2024) Sterile activation of RNA-sensing pathways in autoimmunity. J Mol Cell Biol 16(7):mjae029. https:\/\/doi.org\/10.1093\/jmcb\/mjae029","DOI":"10.1093\/jmcb\/mjae029"},{"key":"9022_CR235","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s12602-024-10214-6","volume":"16","author":"SB Mudaliar","year":"2024","unstructured":"Mudaliar SB, Poojary SS, Bharath Prasad AS, Mazumder N (2024) Probiotics and paraprobiotics: effects on Microbiota-gut-brain axis and their consequent potential in neuropsychiatric therapy. Probiotics Antimicrob Proteins 16:1440\u20131464. https:\/\/doi.org\/10.1007\/s12602-024-10214-6","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"9022_CR236","doi-asserted-by":"publisher","first-page":"991","DOI":"10.51782\/jfmo.v8i1.223","volume":"8","author":"E Kirolos","year":"2024","unstructured":"Kirolos E (2024) Pharmacogenomics: tailoring drug therapy to individual patients. Journal de la facult\u00e9 de m\u00e9decine d Oran 8(1):991\u2013998. https:\/\/doi.org\/10.51782\/jfmo.v8i1.223","journal-title":"Journal de la facult\u00e9 de m\u00e9decine d Oran"},{"key":"9022_CR237","doi-asserted-by":"publisher","first-page":"e20240011","DOI":"10.62958\/j.cjap.2024.011","volume":"40","author":"B Dash","year":"2024","unstructured":"Dash B, Shireen M, Pushpendra et al (2024) A comprehensive review: Pharmacogenomics and personalized medicine customizing drug therapy based on individual genetics profiles. Zhongguo Ying Yong Sheng Li Xue Za Zhi 40:e20240011. https:\/\/doi.org\/10.62958\/j.cjap.2024.011","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"9022_CR238","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/14712598.2024.2384000","volume":"24","author":"AI Venetsanopoulou","year":"2024","unstructured":"Venetsanopoulou AI, Voulgari PV, Drosos AA (2024) Optimizing withdrawal strategies for anti-TNF-\u03b1 therapies in rheumatoid arthritis. Expert Opin Biol Ther 24:815\u2013825","journal-title":"Expert Opin Biol Ther"},{"key":"9022_CR239","first-page":"6","volume":"30","author":"E Dinetz","year":"2024","unstructured":"Dinetz E, Lee E (2024) Comprehensive review of the safety and efficacy of thymosin alpha 1 in human clinical trials. Altern Ther Health Med 30:6\u201312","journal-title":"Altern Ther Health Med"},{"key":"9022_CR240","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41423-024-01206-1","volume":"21","author":"TJC Collins","year":"2024","unstructured":"Collins TJC, Morgan PK, Man K et al (2024) The influence of metabolic disorders on adaptive immunity. Cell Mol Immunol 21:1109\u20131119. https:\/\/doi.org\/10.1038\/s41423-024-01206-1","journal-title":"Cell Mol Immunol"},{"key":"9022_CR241","first-page":"245","volume":"11","author":"G Trimarchi","year":"2024","unstructured":"Trimarchi G, Pizzino F, Paradossi U, Gueli IA, Palazzini M, Gentile P et al (2024) Charting the unseen: how non-invasive imaging could redefine cardiovascular prevention. J Cardiovasc Dev Dis 11:245","journal-title":"J Cardiovasc Dev Dis"},{"key":"9022_CR242","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaclp.2023.08.005","volume":"65","author":"T Hickox","year":"2024","unstructured":"Hickox T, Brahmbhatt K, Smith JR, Fuchs C, Tanguturi Y (2024) Consultation-liaison case conference: systemic challenges in management of aggression in a pediatric patient with seronegative autoimmune encephalitis. J Acad Consult-Liaison Psychiatry 65:66\u201375","journal-title":"J Acad Consult-Liaison Psychiatry"},{"key":"9022_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152479","volume":"67","author":"R Ohno","year":"2024","unstructured":"Ohno R, Nakamura A (2024) Advancing autoimmune rheumatic disease treatment: CAR-T cell therapies - evidence, safety, and future directions. Semin Arthritis Rheum 67:152479. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152479","journal-title":"Semin Arthritis Rheum"},{"key":"9022_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103578","volume":"23","author":"J Xing","year":"2024","unstructured":"Xing J, Wang K, Xu Y-C et al (2024) Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies. Autoimmun Rev 23:103578. https:\/\/doi.org\/10.1016\/j.autrev.2024.103578","journal-title":"Autoimmun Rev"},{"key":"9022_CR245","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2024.09.012","volume":"87","author":"R Li","year":"2025","unstructured":"Li R, Linscott J, Catto JWF et al (2025) FGFR inhibition in urothelial carcinoma. Eur Urol 87:110\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2024.09.012","journal-title":"Eur Urol"},{"key":"9022_CR246","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.molmed.2024.04.009","volume":"30","author":"Z Mukhatayev","year":"2024","unstructured":"Mukhatayev Z, Le Poole IC (2024) Vitiligo: advances in pathophysiology research and treatment development. Trends Mol Med 30:844\u2013862. https:\/\/doi.org\/10.1016\/j.molmed.2024.04.009","journal-title":"Trends Mol Med"},{"key":"9022_CR247","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/dmpt-2024-0003","volume":"39","author":"MA Zahra","year":"2024","unstructured":"Zahra MA, Al-Taher A, Alquhaidan M, Hussain T, Ismail I, Raya I et al (2024) The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease. Drug Metab Personalized Ther 39:47\u201358","journal-title":"Drug Metab Personalized Ther"},{"key":"9022_CR248","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/cancers16050862","volume":"16","author":"H-Y Wang","year":"2024","unstructured":"Wang H-Y, Lin W-Y, Zhou C, Yang Z-A, Kalpana S, Lebowitz MS (2024) Integrating artificial intelligence for advancing multiple-cancer early detection via serum biomarkers: a narrative review. Cancers 16:862","journal-title":"Cancers"},{"key":"9022_CR249","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, Al Bakir M, Hamilton EG, Diehn M, Andr\u00e9 F, Roy-Chowdhuri S et al (2024) Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell 187:1617\u20131635","journal-title":"Cell"},{"key":"9022_CR250","doi-asserted-by":"publisher","unstructured":"Mishchenko TA, Turubanova VD, Gorshkova EN et al (2024) Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1299064","DOI":"10.3389\/fimmu.2023.1299064"},{"key":"9022_CR251","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2665-9913(24)00082-1","volume":"6","author":"RJ Hollick","year":"2024","unstructured":"Hollick RJ, James WR, Nicoll A, Locock L, Black C, Dhaun N et al (2024) Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study. Lancet Rheumatol 6:e361\u2013e373","journal-title":"Lancet Rheumatol"},{"key":"9022_CR252","first-page":"142","volume":"7","author":"EP Adeghe","year":"2024","unstructured":"Adeghe EP, Okolo CA, Ojeyinka OT (2024) A review of wearable technology in healthcare: monitoring patient health and enhancing outcomes. OARJ Multidiscip Stud 7:142\u2013148","journal-title":"OARJ Multidiscip Stud"},{"key":"9022_CR253","doi-asserted-by":"publisher","first-page":"1279192","DOI":"10.3389\/fsci.2024.1279192","volume":"2","author":"I Agache","year":"2024","unstructured":"Agache I, Akdis C, Akdis M, Al-Hemoud A, Annesi-Maesano I, Balmes J et al (2024) Immune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation. Front Sci 2:1279192","journal-title":"Front Sci"},{"key":"9022_CR254","doi-asserted-by":"publisher","unstructured":"Vegesna VV, Adepu A, Whig P (2024) IT for healthcare and food safety enhancing public health through technology integration. In: Advances in medical diagnosis, treatment, and care. IGI Global, pp 525\u2013546. https:\/\/doi.org\/10.4018\/979-8-3693-5528-2.ch020","DOI":"10.4018\/979-8-3693-5528-2.ch020"},{"key":"9022_CR255","doi-asserted-by":"publisher","first-page":"1417684","DOI":"10.3389\/fpubh.2024.1417684","volume":"12","author":"F Pistollato","year":"2024","unstructured":"Pistollato F, Burkhart G, Deceuninck P, Bernasconi C, Di Virgilio S, Emili L et al (2024) What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate. Front Public Health 12:1417684","journal-title":"Front Public Health"},{"key":"9022_CR256","doi-asserted-by":"publisher","unstructured":"Sverdlov O, McIntosh A, Aksenov S, LeClair J. Statistical innovation for gene therapy development: clinical trial design and analysis considerations. In: Development of gene therapies. Chapman and Hall\/CRC, pp 217\u2013250. https:\/\/doi.org\/10.1201\/9781003230342-10","DOI":"10.1201\/9781003230342-10"},{"key":"9022_CR257","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/RHU.0000000000002050","volume":"30","author":"C Howe","year":"2024","unstructured":"Howe C, Smith ID, Coles TM, Overton R, Economou-Zavlanos N, Solomon MJ et al (2024) Evaluating provider perceptions of telehealth utility in outpatient rheumatology telehealth encounters. JCR J Clin Rheumatol 30:46\u201351","journal-title":"JCR J Clin Rheumatol"},{"key":"9022_CR258","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/healthcare12111132","volume":"12","author":"M Haimi","year":"2024","unstructured":"Haimi M, Lerner A (2024) Utilizing telemedicine applications in celiac disease and other gluten-free-diet-dependent conditions: insights from the COVID-19 pandemic. Healthcare (Basel) 12:1132. https:\/\/doi.org\/10.3390\/healthcare12111132","journal-title":"Healthcare (Basel)"},{"key":"9022_CR259","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4324\/9781003431077","volume-title":"Transforming leadership, improving the patient experience: communication strategies for driving patient satisfaction","author":"AT Belasen","year":"2024","unstructured":"Belasen AT, Eisenberg B, Borgos J (2024) Transforming leadership, improving the patient experience: communication strategies for driving patient satisfaction. CRC Press, p 244"},{"key":"9022_CR260","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41584-024-01149-x","volume":"20","author":"MH Buch","year":"2024","unstructured":"Buch MH, Mallat Z, Dweck MR et al (2024) Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases. Nat Rev Rheumatol 20:614\u2013634. https:\/\/doi.org\/10.1038\/s41584-024-01149-x","journal-title":"Nat Rev Rheumatol"},{"key":"9022_CR261","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13300-023-01527-w","volume":"15","author":"MN Ashraf","year":"2024","unstructured":"Ashraf MN, Cheng AY, Robinson DJ (2024) Emotional, psychological, and social well-being experience of long-term living with type 1 diabetes mellitus: a patient\u2013psychiatrist\u2013endocrinologist perspective. Diabetes Ther 15:317\u2013323","journal-title":"Diabetes Ther"},{"key":"9022_CR262","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/cancers16122211","volume":"16","author":"L Mazzoccoli","year":"2024","unstructured":"Mazzoccoli L, Liu B (2024) Dendritic cells in shaping anti-tumor T cell response. Cancers 16:2211","journal-title":"Cancers"},{"key":"9022_CR263","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1037\/prj0000558","volume":"47","author":"CA Harb","year":"2024","unstructured":"Harb CA, Taylor MJ (2024) The utility of community-based participatory research: Increasing research engagement among minoritized ethnoracial groups. Psychiatr Rehabil J 47:22","journal-title":"Psychiatr Rehabil J"},{"key":"9022_CR264","doi-asserted-by":"crossref","unstructured":"McFarlane SJ, Occa A, Peng W, Awonuga O, Morgan SE, about African American Lax et al (2024) Community-based participatory research (CBPR) to enhance participation of racial\/ethnic minorities in clinical trials: a 10-year systematic review. 19\u201336","DOI":"10.4324\/9781032661285-3"},{"key":"9022_CR265","doi-asserted-by":"publisher","first-page":"1384229","DOI":"10.3389\/fimmu.2024.1384229","volume":"15","author":"A Barnado","year":"2024","unstructured":"Barnado A, Moore RP, Domenico HJ, Green S, Camai A, Suh A et al (2024) Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model. Front Immunol 15:1384229","journal-title":"Front Immunol"},{"key":"9022_CR266","doi-asserted-by":"publisher","DOI":"10.2196\/45826","volume":"11","author":"EO Oluokun","year":"2024","unstructured":"Oluokun EO, Adedoyin FF, Dogan H, Jiang N (2024) Co-designing digital health intervention for monitoring medication and consultation among transgender people in underserved communities: collaborative approach. JMIR Hum Factors 11:e45826","journal-title":"JMIR Hum Factors"},{"key":"9022_CR267","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/tropicalmed9110280","volume":"9","author":"A Sparrow","year":"2024","unstructured":"Sparrow A, Smith-Torino M, Shamamba SM, Chirakarhula B, Lwaboshi MA, Benn CS et al (2024) A risk management approach to global pandemics of infectious disease and anti-microbial resistance. Trop Med Infect Dis 9:280","journal-title":"Trop Med Infect Dis"},{"issue":"11","key":"9022_CR268","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.oneear.2024.09.022","volume":"7","author":"R Ni","year":"2024","unstructured":"Ni R, Su H, Burnett RT, Guo Y, Cheng Y (2024) Long-term exposure to PM2. 5 has significant adverse effects on childhood and adult asthma: a global meta-analysis and health impact assessment. One Earth 7(11):1953\u20131969. https:\/\/doi.org\/10.1016\/j.oneear.2024.09.022","journal-title":"One Earth"},{"key":"9022_CR269","doi-asserted-by":"publisher","first-page":"1336042","DOI":"10.3389\/fresc.2024.1336042","volume":"5","author":"M Rehani","year":"2024","unstructured":"Rehani M, Stafinski T, Round J, Jones CA, Hebert JS (2024) Bone-anchored prostheses for transfemoral amputation: a systematic review of outcomes, complications, patient experiences, and cost-effectiveness. Front Rehabil Sci 5:1336042","journal-title":"Front Rehabil Sci"},{"key":"9022_CR270","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.3390\/ijms25137284","volume":"25","author":"S Isola","year":"2024","unstructured":"Isola S, Gammeri L, Furci F, Gangemi S, Pioggia G, Allegra A (2024) Vitamin C supplementation in the treatment of autoimmune and onco-hematological diseases: from prophylaxis to adjuvant therapy. Int J Mol Sci 25:7284","journal-title":"Int J Mol Sci"},{"key":"9022_CR271","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","volume":"132","author":"DK Chu","year":"2024","unstructured":"Chu DK, Schneider L, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K et al (2024) Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE\u2013and Institute of Medicine\u2013based recommendations. Ann Allergy Asthma Immunol 132:274\u2013312","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9022_CR272","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ph17070881","volume":"17","author":"FM Elgarhy","year":"2024","unstructured":"Elgarhy FM, Borham A, Alziny N, AbdElaal KR, Shuaib M, Musaibah AS et al (2024) From drug discovery to drug approval: a comprehensive review of the pharmacogenomics status quo with a special focus on Egypt. Pharmaceuticals 17:881","journal-title":"Pharmaceuticals"},{"key":"9022_CR273","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1377\/hlthaff.2023.00843","volume":"43","author":"SL Schaefer","year":"2024","unstructured":"Schaefer SL, Dualeh SH, Kunnath N, Scott JW, Ibrahim AM (2024) Higher rates of emergency surgery, serious complications, and readmissions in primary care shortage areas, 2015\u201319: study examines rates of emergency surgery, serious complications, and readmissions in primary care shortage areas. Health Aff 43:363\u2013371","journal-title":"Health Aff"},{"key":"9022_CR274","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.2147\/jpr.s480559","volume":"17","author":"R D\u2019Souza","year":"2024","unstructured":"D\u2019Souza R, Her Y, Hussain N et al (2024) Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: a consensus report from a multispecialty working group. J Pain Res 17:2951\u20133001. https:\/\/doi.org\/10.2147\/jpr.s480559","journal-title":"J Pain Res"},{"key":"9022_CR275","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12281-024-00482-8","volume":"18","author":"S Rhoads","year":"2024","unstructured":"Rhoads S, Maloney J, Mantha A, Van Hook R, Henao-Mart\u00ednez AF (2024) Pneumocystis jirovecii pneumonia in HIV-negative, non-transplant patients: epidemiology, clinical manifestations, diagnosis, treatment, and prevention. Curr Fungal Infect Rep 18:125\u2013135","journal-title":"Curr Fungal Infect Rep"},{"key":"9022_CR276","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/17460441.2024.2319672","volume":"19","author":"I Strassl","year":"2024","unstructured":"Strassl I, Podar K (2024) The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma. Expert Opin Drug Discov 19:377\u2013391","journal-title":"Expert Opin Drug Discov"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09022-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09022-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09022-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:56:54Z","timestamp":1739447814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09022-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":276,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9022"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09022-9","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14"}}